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he small GTPase RhoA controls activity of serum
response factor (SRF) by inducing changes in actin
dynamics. We show that in PC12 cells, activation of
SRF after serum stimulation is RhoA dependent, requiring
both actin polymerization and the Rho kinase (ROCK)–LIM
kinase (LIMK)–coﬁlin signaling pathway, previously shown to
control F-actin turnover. Activation of SRF by overexpression
of wild-type LIMK or ROCK-insensitive LIMK mutants also
T
 
requires functional RhoA, indicating that a second RhoA-
dependent signal is involved. This is provided by the RhoA
effector mDia: dominant interfering mDia1 derivatives inhibit
both serum- and LIMK-induced SRF activation and reduce
the ability of LIMK to induce F-actin accumulation. These
results demonstrate a role for LIMK in SRF activation, and
functional cooperation between RhoA-controlled LIMK
and mDia effector pathways.
 
Introduction
 
The Rho family of Ras-related GTPases are involved in the
control of many cellular processes, including cytoskeletal
organization, cell cycle control, and transformation, and
transcriptional regulation (for reviews see Van Aelst and
D’Souza-Schorey, 1997; Bishop and Hall, 2000). The Rho
family GTPase RhoA controls the formation of actin
structures by interacting with a set of effector proteins
that includes the Rho kinases (ROCKs; also known as
ROKs), myosin light chain (MLC)* phosphatase, PI4-P
5-kinase, and the Diaphanous group of formin proteins
(mDia proteins; for reviews see Kaibuchi et al., 1999;
Amano et al., 2000). The ROCK kinases play several roles
in RhoA-induced actin reorganization. They control actin
filament bundling by phosphorylating MLC and inhibiting
MLC phosphatase (Amano et al., 1996; Kimura et al.,
1996); regulate synthesis of PI-4,5P, an important regulator
of cytoskeletal remodelling (Sechi and Wehland, 2000), by
controlling the activity of PI-4P 5-kinase (Oude Weernink et
al., 2000); and promote F-actin accumulation by activating
LIM kinases (LIMKs), which phosphorylate and inactivate
the actin filament depolymerizing/severing factor cofilin
(Arber et al., 1998; Yang et al., 1998; Maekawa et al., 1999;
Sumi et al., 1999; Ohashi et al., 2000). The mDia proteins
also induce F-actin assembly. In this case, binding of Rho
appears to relieve an autoinhibitory interaction between the
mDia NH
 
2
 
- and COOH-terminal sequences; this allows
their conserved formin-homologous domains to promote
F-actin assembly via an unknown mechanism (Watanabe et
al., 1997, 1999; Tominaga et al., 2000; Alberts, 2001). The
mDia proteins cooperate with ROCK kinases to promote
actin stress fiber formation (Nakano et al., 1999; Watanabe et
al., 1999; Tominaga et al., 2000), but the involvement of
ROCK-induced LIMK activation in this process has not
been addressed directly.
Recent studies have identified a direct link between the
ability of Rho GTPases to control actin polymerization and
the ability to regulate transcriptional activation by serum
response factor (SRF). SRF, a MADS-box transcription
factor, controls the activities of many growth factor–inducible
 
and muscle-specific genes (Shore and Sharrocks, 1995;
Arsenian et al., 1998). Serum- and mitogen-activated SRF
activity is RhoA dependent, and activated forms of Rho
family GTPases can activate SRF in the absence of extracellular
stimuli (Hill et al., 1995). Signal-induced SRF activation
can be inhibited both by blockade of actin polymerization
and by overexpression of nonpolymerizable derivatives of
cytoskeletal actin (Sotiropoulos et al., 1999; Tominaga et al.,
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2000; unpublished data). In addition, certain actin-binding
drugs and constitutively active forms of regulators of actin po-
lymerization, such as LIMK, mDia, the Wiskott-Aldrich Syn-
drome protein (WASP) family, and vasodilator-stimulated
phosphoprotein (VASP), can potentiate SRF activity in the ab-
sence of extracellular signals (Sotiropoulos et al., 1999; Tomi-
naga et al., 2000; unpublished data). These results have led to
the proposal that SRF is somehow activated in response to de-
pletion of the cellular G-actin pool (Sotiropoulos et al., 1999).
The RhoA–actin signaling pathway regulates a subset of
SRF target genes including vinculin, 
 
 
 
-actin, SRF itself,
SM22, and sm-
 
 
 
 actin (Sotiropoulos et al., 1999; Gineitis
and Treisman, 2001; Mack et al., 2001). However, the sig-
naling pathways linking RhoA to actin polymerization and
SRF activity appear to vary between cell types. In NIH3T3
cells, SRF activation requires the RhoA effector mDia
(Tominaga et al., 2000; unpublished data) but not ROCK
or LIMK (Sahai et al., 1998, 1999; Sotiropoulos et al.,
1999). In rat aortic smooth muscle cells, by contrast, ROCK
does contribute to SRF activation, although it remains un-
clear whether LIMK and mDia are also involved (Mack et
al., 2001). In this work, we have investigated the role of
LIMK signaling to SRF using the rat PC12 phaeochromocy-
toma cell line, prompted by previous reports that LIMK ex-
pression is pronounced in cells of neural origin (Cheng and
Robertson, 1995; Proschel et al., 1995). We show that in
PC12 cells, the ROCK–LIMK–cofilin–actin pathway plays
an important role in signaling to SRF. In addition, both se-
rum- and LIMK-induced SRF activity is dependent on
mDia, which is also required for LIMK1-induced F-actin
accumulation in PC12 cells. Our results reveal functional
cooperation between mDia and LIMK, consistent with a
 
model in which Rho-dependent LIMK activation regulates
the stability of mDia-dependent F-actin.
 
Results
 
Activation of SRF via the ROCK–LIMK–cofilin pathway 
in neuronal cell lines
 
LIMK has been reported to be expressed at high level in the
CNS (Cheng and Robertson, 1995; Proschel et al., 1995).
Moreover, stimulation of N1E-115 neuroblastoma cells
with lysophosphatidic acid induces the phosphorylation
and activation of LIMKs via the RhoA effector ROCK
(Maekawa et al., 1999). We therefore investigated the
involvement of the ROCK–LIMK effector pathway in
SRF activation in neuronal cell lines. N1E-115, PC12,
SKNMC, and Neuro2A cells were transfected with the
SRF-controlled reporter gene 3D.Aluc, maintained in 0.5%
serum for 40 h and then restimulated with 15% serum for
8 h before analysis of reporter gene activity (see Materials
and methods). Serum induction of the reporter gene in
N1E-115 cells was inefficient and not pursued further (un-
published data). In PC12, SKNMC, and Neuro2A cells,
however, serum stimulation resulted in robust reporter gene
activation; this was dependent on RhoA, as it was abolished
by coexpression of C3 transferase, which ADP ribosylates
and thereby inactivates RhoA (Fig. 1 A).
We next evaluated the potential contribution of the
ROCK–LIMK–cofilin pathway to serum-induced SRF activa-
tion. Overexpression of the nonphosphorylatable cofilin mu-
tant cofilin S3A can block activation of SRF by overexpressed
LIMK1 (Sotiropoulos et al., 1999). To inhibit ROCK activity,
we exploited the kinase-inactive ROCK mutant ROCK
 
 
 
3-
Figure 1. Serum-induced activation of 
SRF reporter requires the ROCK–LIMK–
cofilin pathway in PC12, SKNMC, and 
Neuro2A cells. (A) The different cell 
types were transfected with the SRF 
reporter together with expression plasmids 
encoding C3 transferase (50 ng), 
nonphosphorylatable cofilin S3A (0.5 or 
2.0  g), kinase-inactive LIMK1 kinase 
domain (K1C.D460A) (0.5 or 1.0  g), or 
kinase-inactive ROCK 3 K105A (0.5 or 
2.0  g) as indicated, or treated with 
latrunculin B (LB; 0.5  M) or Y27632 
(10  M). Serum induction of reporter 
activity was measured and quantitated 
as described in the Materials and 
methods; error bars show SEM (n   3) 
for PC12 and Neuro2A, and half range 
(n   2) for SKNMC. (B) SRF activation by 
serum stimulation does not require the 
ROCK–LIMK–cofilin pathway in 
NIH3T3 cells. NIH3T3 cells were 
transfected with the SRF reporter and 
expression plasmids as in A. Reporter 
activity was measured and quantitated 
taking serum-induced level as 100%. Error bars show half range (n   2). (C) Activation of SRF by Rho GTPases and actin-binding drugs in 
PC12 cells. Cells were transfected with the SRF reporter and either cotransfected with expression plasmids encoding RhoA.V14 (1.0  g), 
Rac1.V12 (0.3  g), Cdc42.V12 (0.3  g), or N-WASP minimal F-actin–nucleating VCA domain (0.3  g), or treated with 2  M cytochalasin D 
or 0.5  M jasplakinolide before reporter activity was measured. (D) Serum-induced activation of the SRF target gene vinculin requires 
functional ROCK in PC12 cells. Serum-starved PC12 cells were serum stimulated with or without Y27632 pretreatment as indicated. Total 
RNA was analyzed for vinculin and GAPDH transcripts by RNA’ase protection. 
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K105A (Ishizaki et al., 1997) and the small molecule ROCK
inhibitor Y27632 (Uehata et al., 1997; Ishizaki et al., 2000). In
PC12, SKNMC, and Neuro2A cells, serum induction of the
SRF reporter was substantially blocked by expression of cofilin
S3A or ROCK
 
 
 
3-K105A (Fig. 1 A). Because PC12 exhibited
both a robust induction of the reporter and a high absolute
level of activity, we focused our attention on these cells for fur-
ther experiments. In PC12 cells, SRF reporter activity was also
effectively blocked by expression of a kinase-inactive LIMK1
derivative D460A (Edwards and Gill, 1999), and upon inhibi-
tion of ROCK activity by Y27632 (Fig. 1 A). Together these
data suggest that in all three neuronal cell lines, the ROCK–
LIMK–cofilin pathway is essential for SRF activation. In con-
trast, neither cofilin nor LIMK appeared required for SRF
activation in NIH3T3 cells (Fig. 1 B), in agreement with our
previous finding that ROCK activity is not essential for SRF
activation in these cells (Sahai et al., 1999).
We used PC12 cells to characterize the involvement of Rho
signaling and actin dynamics in signaling to SRF in more detail.
SRF reporter activation was blocked by treatment of the cells
with latrunculin B, which inhibits actin polymerization by se-
questration of G-actin (Fig. 1 A, left). Expression of the GTP-
ase-defective RhoA mutant RhoA.V14 activated SRF as effi-
ciently as serum stimulation (Fig. 1 C), as previously observed
in NIH3T3 fibroblasts (Hill et al., 1995). In addition, the ac-
tin-binding drugs jasplakinolide and cytochalasin D strongly
activate SRF in PC12 as well as in NIH3T3 cells (Fig. 1 C)
(Sotiropoulos et al., 1999). Activated forms of the Rho-related
GTPases Rac1 and Cdc42 also activated SRF in PC12 cells,
this was more efficient than RhoA, as did the minimal actin fil-
ament–nucleating domain of neural (N)-WASP, VCA (re-
viewed by Higgs and Pollard, 2001), which functions only
weakly in NIH3T3 cells (Sotiropoulos et al., 1999) (Fig. 1 C).
We used Y27632 treatment to test the involvement of
ROCK signaling in activation in PC12 cells of a bona fide SRF
target gene, vinculin, which in fibroblasts is dependent on
RhoA–actin signaling (Sotiropoulos et al., 1999; Gineitis and
Treisman, 2001). Vinculin transcripts increased approximately
fourfold over a 2-h period after serum stimulation, and this was
substantially blocked by Y27632 pretreatment (Fig. 1 D).
Thus, in PC12 cells, SRF regulation is dependent on a RhoA–
ROCK–LIMK–cofilin signaling cascade.
 
Cofilin phosphorylation in PC12 cells is Rho dependent
 
To obtain more direct evidence for changes in LIMK activity
upon serum stimulation of PC12 cells, we used two-dimen-
sional (2D) gel electrophoresis and immunoblotting to examine
cofilin phosphorylation. In both cycling or serum-starved PC12
cell extracts, cofilin migrated as two predominant species of 19
kD, presumably representing cofilin and actin depolymerizing
factor, which should cross react with the antiserum used (Fig. 2
A, top, arrows). Serum stimulation induced the appearance of
an additional spot, which was sensitive to treatment of the cells
with Y27632 (Fig. 2 A, middle, arrow). This species was also
sensitive to phosphatase treatment, indicating that it is a phos-
phorylated derivative of cofilin (Fig. 2 A, bottom, arrow).
To allow investigation of the role of RhoA and its effectors
in signaling to SRF via LIMK, we set up a simple cofilin re-
porter assay. Extracts from transfected cells expressing FLAG
epitope–tagged cofilin were subjected to 2D gel electrophore-
sis followed by immunoblotting with FLAG antibody. Wild-
type FLAG–cofilin generated two species in this assay. The
more acidic of these represents the phosphorylated form, be-
cause it is not generated by the nonphosphorylatable mutant
cofilin S3A, and is sensitive to phosphatase treatment (Fig. 2
B, arrows). The ratio of phosphorylated to nonphosphory-
lated FLAG–cofilin observed in serum-starved cells varied be-
tween experiments, increasing as cofilin expression increased
(Fig. 2 D, middle and bottom), perhaps reflecting homeo-
static adjustment of the treadmilling machinery to maintain
the F-actin level. We therefore only compared FLAG–cofilin
phosphorylation levels within a given experiment. Serum star-
vation caused a reduction in the amount of phosphorylated
FLAG–cofilin relative to the unphosphorylated form (Fig. 2
Figure 2. Cofilin phosphorylation via 
the Rho pathway in PC12 cells. The 2D 
gels are shown with acidic isoelectric 
point to the right, SDS-PAGE top to 
bottom. (A) Serum-induced phosphory-
lation of endogenous cofilin requires 
ROCK activity. PC12 cells were 
maintained in 0.5% serum before 
stimulation with 15% serum with or 
without Y27632 (Y) pretreatment. Cell 
extracts were prepared and fractionated 
by 2D gel electrophoresis; cofilin was 
detected by immunoblotting. Where 
indicated, extracts were treated with 
alkaline phosphatase (P’tase) before 
analysis. (B) FLAG–cofilin reporter assay. 
PC12 cells transfected with the indicated 
FLAG–cofilin expression plasmids (0.2  g) 
were analyzed by 2D gel electrophoresis 
and immunoblotting with anti-FLAG 
antibody; phosphatase treatment was 
performed on anti-FLAG immunoprecipitates. (C) Phosphorylation status of FLAG–cofilin under different growth conditions. Cells transfected 
with wild-type FLAG–cofilin expression plasmids were maintained as indicated and analyzed as in part B. Only the cofilin species are 
shown; the positions of unphosphorylated and phosphorylated forms are indicated above the figure. (D) Serum-induced phosphorylation of 
FLAG–cofilin requires RhoA and ROCK activity. Cells transfected with expression plasmids encoding wild-type FLAG–cofilin and C3 transferase 
(50 ng), as indicated, were serum starved and restimulated with 15% serum for 5 min; Y27632 treatment (Y) was as indicated. 
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C, top and middle). Upon serum stimulation, increased phos-
phorylation of FLAG–cofilin was detectable within 5 min and
persisted for at least 30 min (Fig. 2 C, bottom). Serum-
induced FLAG–cofilin phosphorylation did not occur in cells
expressing C3 transferase or treated with Y27632, indicating
that it depends on RhoA–ROCK signaling (Maekawa et al.,
1999; Ohashi et al., 2000) (Fig. 2 D, top and middle); C3 or
Y27632 treatment also slightly but consistently reduced the
proportion of phosphorylated FLAG–cofilin in serum-starved
cells, suggesting that the basal level of LIMK activity is also
significantly dependent on RhoA (Fig. 2 D, bottom).
 
SRF activation via ROCK and LIMK requires 
functional RhoA
 
The data presented above show that ROCK–LIMK signal-
ing is required for serum-induced SRF activation in PC12
cells. We used C3 transferase expression to test whether this
is the only RhoA-dependent event required for signaling to
SRF in these cells. In parallel, we examined the effects of C3
transferase upon cofilin phosphorylation using the FLAG–
cofilin transfection assay. As expected, C3 transferase expres-
sion abolished SRF activation by RhoA.V14 (Fig. 3 A).
Surprisingly, C3 expression also abolished SRF activation
by overexpressed LIMK1 (Fig. 3 A), although it did not in-
hibit induction of FLAG–cofilin phosphorylation by LIMK1
(Fig. 3 B, top). This result suggests that LIMK activation of
SRF requires an additional RhoA-dependent event, even in
starved cells with only basal levels of RhoA activity.
The RhoA effector kinase ROCK activates LIMK1 by phos-
phorylating it at a single site, T508 (Maekawa et al., 1999;
Ohashi et al., 2000), and we therefore tested whether the sensi-
tivity of LIMK1 to C3 transferase reflected the involvement of
RhoA–ROCK signaling in LIMK activation. First, we exam-
ined whether functional RhoA is required for SRF activation
induced by the activated ROCK derivative, ROCK
 
 
 
3, which
should activate LIMK1 independently of RhoA (Maekawa et
al., 1999; Ohashi et al., 2000). ROCK
 
 
 
3 activated SRF with
an efficiency comparable to that of RhoA.V14, but as observed
with LIMK1, this was sensitive to C3 transferase (Fig. 3 A).
Expression of ROCK
 
 
 
3 also induced phosphorylation of
FLAG–cofilin, which was not blocked by C3 expression al-
though it was somewhat reduced (Fig. 3 B, middle). Next, we
examined SRF activation by LIMK T508V, in which the tar-
get site for ROCK phosphorylation is replaced with a non-
phosphorylatable valine residue (Fig. 3 D); such mutants retain
some catalytic activity both in vitro and in vivo (Edwards and
Gill, 1999; Ohashi et al., 2000). Expression of the wild-type
LIMK1 kinase domain efficiently activated SRF, and this was
again substantially RhoA dependent (Fig. 3 C), although at
high expression levels some C3-resistant SRF activation was
observed (unpublished data; see Discussion). Overexpression
of the LIMK1-T508V kinase domain also activated SRF, al-
though substantially less efficiently than wild type; however,
activation was still RhoA dependent (Fig. 3 C). Under trans-
fection conditions in which expression levels of wild-type and
T508V LIMK were adjusted to give similar levels of SRF acti-
vation, both proteins induced a similar degree of FLAG–cofilin
phosphorylation, which was not impaired by coexpression of
C3 transferase (Fig. 3 B, bottom). Taken together, these results
show that to activate SRF in PC12 cells, LIMK requires a sec-
ond Rho-dependent signal, which must regulate a process dis-
tinct from cofilin phosphorylation.
 
mDia is required for SRF activation in PC12 cells
 
The RhoA effector mDia promotes F-actin accumulation and is
required for serum-induced SRF activation in NIH3T3 cells
(Tominaga et al., 2000; unpublished data). We therefore inves-
tigated its role in signaling to SRF in PC12 cells. An activated
form of mDia1, mDia1*, which lacks the RhoA-binding do-
main (Watanabe et al., 1999), efficiently activated SRF in
PC12 cells (Fig. 4 A). In contrast to SRF activation by LIMK,
activation of SRF by mDia1* was substantially unaffected by
coexpression of C3 transferase, indicating that it did not require
functional Rho (Fig. 4 B). Expression of activated mDia1 did
not alter the proportion of phosphorylated FLAG–cofilin gen-
erated in the cofilin reporter assay (Fig. 4 C, top), indicating
that it does not activate SRF by regulating LIMK activity.
Figure 3. LIMK1 requires an additional RhoA-dependent event to 
activate SRF. (A) Sensitivity of SRF activation to C3 transferase. PC12 
cells were transfected with the SRF reporter and expression plasmids 
encoding RhoA.V14 (1.0  g), LIMK1 (1.0  g), or ROCK 3 (60 ng), 
and C3 transferase (50 ng) as indicated, and reporter activity was 
measured. (B) FLAG–cofilin phosphorylation does not require RhoA. 
Cells were transfected with expression plasmids encoding wild-type 
FLAG–cofilin (0.2  g) alone or with LIMK1 (1.0  g), ROCK 3 (30 ng), 
LIMK1 kinase domain K1.C (0.1  g), or ROCK-insensitive LIMK1 
kinase domain mutant K1.C/T508V (1.0  g), and C3 transferase (50 
ng) as indicated, before processing by 2D gel electrophoresis followed 
by anti-FLAG immunoblot. Only the FLAG–cofilin species are shown; 
the positions of unphosphorylated and phosphorylated forms are 
indicated above the figure. (C) SRF activation by LIMK1 T508V 
requires RhoA. Cells were transfected with the SRF reporter and 
expression plasmids encoding LIMK1 kinase domain K1.C (0.1  g) or 
ROCK-insensitive LIMK1 kinase domain mutant K1.C/T508V (0.1, 0.3, 
or 1.0  g), with C3 transferase (50 ng) as indicated, and reporter 
activity was measured. (D) LIMK1 derivatives. The LIMK1 coding 
region is indicated at the top with LIM, PDZ, and kinase domains 
shown as boxes; the K1.C kinase domain (residues 293–646) is shown 
below and its ROCK-insensitive mutant T508V is also indicated. 
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Thus, mDia provides an alternative route to the ROCK–LIMK
pathway for signaling to SRF downstream of RhoA.
To evaluate the contribution of mDia proteins to serum-
induced SRF activation, we used an inactivated mDia1 deriva-
tive that can interfere with SRF activation when overexpressed
in NIH3T3 cells. This mutant, dnDia1, lacks the NH
 
2
 
-termi-
nal RhoA-binding domain of mDia1 and sequences within the
COOH-terminal domain (Fig. 4 A; unpublished data). In
PC12 cells, dnDia1 expression did not activate SRF, but in-
stead substantially inhibited SRF activation after serum stimula-
tion (Figs. 4 D and 5 A). Importantly, expression of dnDia1
did not prevent the increase in FLAG–cofilin phosphorylation
that occurred upon serum stimulation (Fig. 4 C, middle), indi-
cating that its effect on SRF is specific and does not result from
a nonspecific impairment of Rho signaling. Expression of
dnDia1 was not toxic, as it affected neither the number of GFP-
positive cells nor the thymidine kinase–renilla control reporter
(unpublished data). Expression of cofilin S3A and dnDia1 in-
hibited reporter induction more effectively than dnDia1 alone
(Fig. 4 E). Taken together, these data show that in addition to
the ROCK–LIMK pathway, functional mDia is required for
serum-induced SRF activation in these cells, and activation of
SRF by mDia occurs independently of cofilin phosphorylation.
 
Functional mDia is required for SRF activation by LIMK
 
The data in the preceding sections show that RhoA-mediated
activation of SRF in PC12 cells requires both LIMK and mDia
signaling, and establish mDia as a candidate for the Rho-depen-
dent function required by LIMK for SRF activation. We there-
fore tested whether dnDia1 can interfere with LIMK-induced
SRF activity. Expression of dnDia1 substantially inhibited SRF
activation by overexpressed LIMK1; in contrast, 
 
 
 
Dia1, an in-
active mDia1 derivative that does not inhibit serum-induced
SRF activation, did not inhibit LIMK1-induced SRF activation
(Fig. 5 A). Expression of dnDia1 did not affect the ability of
overexpressed LIMK1 to induce cofilin phosphorylation (Fig. 5
B). Thus, mDia is likely to represent the additional RhoA-
dependent signal required for SRF activation by LIMK.
Because SRF activation is dependent on alterations in actin
dynamics, these results suggest that the ability of LIMK to in-
duce increases in F-actin will also be dependent on mDia activ-
ity. We therefore investigated whether dnDia1 can inhibit the
ability of LIMK1 to increase cellular F-actin content. PC12
cells were transfected with expression plasmids encoding epi-
tope-tagged LIMK1 and mDia1 derivatives, and FACS
 
®
 
analysis of FITC-phalloidin–stained cells was then used to
quantify and compare the mean F-actin content in transfected
and untransfected cell populations (Howard and Meyer, 1984;
Bleul et al., 1996; Burger et al., 1999). We first assessed the
ability of dnDia1 to affect the F-actin level. Expression of
dnDia1 had no significant effect on mean F-actin content (Fig.
5 C). A similar result was obtained with a control mDia1 deriv-
ative, 
 
 
 
Dia1, which neither activates SRF nor interferes with
serum-induced SRF activity in PC12 cells (Fig. 5 C; unpub-
lished data). We then assessed the ability of these two mDia de-
rivatives to affect LIMK1-induced F-actin assembly. Expression
of LIMK1 led to an 
 
 
 
60% increase in the F-actin level in the
presence or absence of 
 
 
 
Dia1; (Fig. 5 C; unpublished data). In
contrast, expression of dnDia1 together with LIMK1 led to a
significant reduction in the ability of LIMK to increase F-actin
Figure 4. mDia activity is required for SRF 
activation in PC12 cells. (A) mDia1 derivatives. 
The mDia1 coding region is indicated at the top 
with RhoA-binding domain as a circle and formin 
homology regions 1–3 as boxes; below are shown 
the activated mDia1 derivative Dia1* (residues 
256–1255), the inactive interfering derivative 
dnDia1 (residues 571–1181, lacking 750–771), 
and the control inactive noninterfering derivative 
 Dia1 (residues 256–567). (B) SRF activation by 
mDia1 in PC12 cells. Cells were transfected with 
the SRF reporter and expression plasmids encoding 
Dia1* (0.3  g) with C3 transferase (50 ng), as 
indicated, and reporter activity was measured. The 
effect of C3 transferase on reporter activation by 
the synthetic activator SRF-VP16 (50 ng) is shown 
for comparison. Error bars show half range (n   2). 
(C) mDia1 does not promote cofilin phosphoryla-
tion. Cells were transfected with expression 
plasmids encoding wild-type FLAG–cofilin (0.2 
 g) alone or with Dia1* (0.3  g), dnDia1 (2.0  g), 
or LIMK1 (1.0  g). After maintenance in 0.5% 
serum with serum stimulation as indicated, cells 
were analyzed for FLAG–cofilin phosphorylation 
by 2D gel electrophoresis followed by anti-FLAG 
immunoblot. Only the FLAG–cofilin species are 
shown; the positions of unphosphorylated and 
phosphorylated forms are indicated above the 
figure. (D) Serum-induced SRF activation requires functional mDia. Left, cells were transfected with the SRF reporter and an expression plasmid 
encoding dnDia1 (2.0  g), as indicated, and either maintained in 0.5% serum or serum stimulated before measurement of reporter activity. 
Serum-stimulated reporter activity is taken as 100%. Error bars show SEM (n   4). (E) Cofilin S3A potentiates the effect of interfering mDia. 
Cells were transfected with the SRF reporter together with expression plasmids encoding dnDia1 (2.0  g) and/or cofilin S3A (0.5 or 2.0  g), 
as indicated, and either was maintained in 0.5% serum or was serum stimulated before quantitation of reporter activity. Serum-induced 
reporter activity is taken as 100%. Error bars show half range (n   2). 
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content, which was increased to only 25% above untransfected
cells (Fig. 5 C). Thus, functional mDia is required for LIMK1
both to promote F-actin assembly and activate SRF.
 
Discussion
 
ROCK-mediated activation of LIMK and phosphorylation of
cofilin are required for serum-induced signaling to SRF in the
PC12 neuronal cell line. In contrast, LIMK1 apparently does
not play a significant role in SRF activation in NIH3T3 cells,
even though SRF is regulated by actin dynamics in these cells
(Sotiropoulos et al., 1999). However, both serum- and LIMK-
induced SRF activation in PC12 cells require a second RhoA-
controlled pathway involving the mDia proteins, which forms
the main regulatory pathway to SRF in NIH3T3 cells (Tomi-
naga et al., 2000; unpublished data). These results, summarized
in Fig. 6, demonstrate functional cooperation between LIMK
and mDia proteins, and strongly support our model in which
SRF activation is brought about by changes in actin dynamics
(Sotiropoulos et al., 1999). Actin assembly and turnover can
also be regulated by other Rho family GTPases (Edwards et al.,
1999; Higgs and Pollard, 2001), and our finding that Cdc42-
and Rac1-induced signaling activates SRF efficiently in PC12
cells suggests that inputs from these GTPases into the actin
treadmilling cycle may also play a role in SRF regulation in
these cells (Fig. 6). Indeed, there is evidence that RhoA may sig-
nal to cofilin exclusively through LIMK2 and Rac through
LIMK1, though there is still some uncertainty regarding this
point (Ohashi et al., 2000; Sumi et al., 2001). However, our ex-
periments do not address whether it is LIMK1 or LIMK2 that
participates in Rho-dependent signaling to SRF in PC12 cells.
Previous studies have shown that Rho family GTPases use
multiple pathways to control the accumulation of F-actin. For
example, RhoA both promotes F-actin assembly via the mDia
proteins (Watanabe et al., 1997, 1999; unpublished data) and
inhibits its turnover via ROCK–LIMK signaling (Maekawa et
al., 1999; Sumi et al., 1999). In contrast, Rac1 and Cdc42 in-
duce F-actin nucleation via WASP/Scar family proteins and in-
hibit F-actin turnover through PAK–LIMK signaling (Edwards
et al., 1999). Although it would appear reasonable to suppose
that in both cases these pathways are somehow constrained to
Figure 5. mDia is required for LIMK1-induced SRF activation and 
F-actin assembly. (A) LIMK1-induced SRF activation requires mDia. 
PC12 cells were transfected with expression plasmids encoding LIMK1 
(1.0  g), inactive mDia derivative  Dia1 (Dia1 256–567; 3.0  g), or 
interfering mDia1 derivative dnDia1 (Figure 4 A; 3.0  g), as indicated, 
together with the SRF reporter plasmid and maintained in 0.5% serum 
before quantitation of reporter activity, taking LIMK1  Dia1 as 100%. 
Error bars show SEM (n   3). (B) dnDia1 does not affect LIMK1-
induced cofilin phosphorylation. Cells were transfected with 
expression plasmids encoding wild-type FLAG–cofilin (0.2  g) alone 
or with LIMK1 (1.0  g) and dnDia1 (2.0  g) as indicated. After 
maintenance in 0.5% serum, cells were analyzed for FLAG–cofilin 
phosphorylation by 2D gel electrophoresis and anti-FLAG immuno-
blot. Only the FLAG–cofilin species are shown; the positions of 
unphosphorylated and phosphorylated forms are indicated above the 
figure. (C) LIMK-induced F-actin accumulation requires mDia activity. 
PC12 cells were transfected with expression plasmids encoding LIMK1 
(1.0  g), inactive mDia derivative  Dia1 (Dia1 256–567; 3.0  g), or 
interfering mDia1 derivative dnDia1 (Figure 4 A; 3.0  g). The mean 
F-actin content in transfected cells was determined using FACS
® 
analysis and expressed relative to the mean F-actin content of 
untransfected cells from the same population, indicated by the dotted 
line (Materials and methods). The chart summarizes three indepen-
dent experiments of this type, presenting the average of the mean 
F-actin content in each population   SEM; statistical significance was 
estimated using the unpaired t test.
Figure 6. Regulatory pathways to SRF via actin dynamics. The actin 
treadmilling cycle is shown schematically with actin monomer as a 
wedge, profilin as a rectangle, and cofilin as a circle. The treadmilling 
cycle is regulated by two Rho effector pathways. The Dia proteins 
promote F-actin accumulation via an uncharacterized mechanism, 
perhaps involving recruitment of profilin–actin to the Dia FH1 domain. 
The ROCK–LIMK–cofilin cascade negatively regulates cofilin activity, 
thereby increasing the F-actin level by inhibiting monomer dissociation 
and F-actin severing. Serum-induced SRF activation in PC12 cells is 
dependent on Rho signaling and actin polymerization, consistent 
with previous findings that SRF activity responds to depletion of the 
cellular G-actin pool or subpopulation of it (Sotiropoulos et al., 
1999; unpublished data). Maximal serum-induced activity in PC12 
cells requires operation of both ROCK–LIMK–cofilin and Dia 
pathways. The ability of LIMK both to activate SRF and to increase 
the F-actin level in PC12 cells is dependent on Dia proteins,
suggesting that the activity of LIMK is targeted to a pool of Dia-
dependent F-actin. 
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act on the same pool of F-actin, no direct evidence for such
functional cooperation has been presented. Our finding that
functional mDia is required for LIMK to induce accumulation
of F-actin provides direct evidence for functional cooperation
between the F-actin assembly and turnover pathways down-
stream of RhoA. A simple model consistent with this observa-
tion is that the primary target for LIMK action is a pool of
F-actin whose accumulation is dependent on a basal level of
RhoA signaling through mDia (Fig. 6). At high expression
levels, however, both LIMK and especially its isolated kinase
domain can activate SRF largely independently of RhoA
(Sotiropoulos et al., 1999; unpublished data), perhaps because
under such conditions LIMK becomes mislocalized and acts on
RhoA-independent F-actin. Our results suggest that the previ-
ously observed cooperation between mDia and ROCK in stress
fiber formation reflects both the F-actin accumulation and actin
filament bundling pathways downstream of ROCK (Nakano et
al., 1999; Watanabe et al., 1999; Tominaga et al., 2000).
Our studies indicate that the relative importance of differ-
ent RhoA effector pathways for SRF activation differs be-
tween cell types. Although mDia function is required both in
NIH3T3 fibroblasts and PC12 cells, ROCK and LIMK
function plays a significant role only in PC12 cells. We spec-
ulate that ROCK–LIMK signaling to SRF may be a general
feature of neuronal cell types. Functional ROCK is also re-
quired for maximal SRF activation in rat aortic smooth mus-
cle cells, although in this case the roles of LIMK and mDia
have not been addressed (Mack et al., 2001). At present, the
molecular basis for the differential involvement of LIMK sig-
naling in SRF activation remains unclear. We think it un-
likely that it reflects cell type–specific expression of LIMK in
the nervous system because LIMKs are detectable in many
cell types. It is unlikely that LIMK is not effectively coupled
to RhoA signaling in NIH3T3 cells, because serum-induced
alterations in cofilin phosphorylation are readily detectable
using the FLAG–cofilin assay (unpublished data). Similarly,
the requirement for mDia activity in PC12 cells indicates
both that this RhoA effector pathway must be functional in
these cells and that it is likely providing a substrate upon
which LIMK signaling can act. It may be that the different
F-actin structures in PC12 cells are organized such that
RhoA-dependent regulation is mediated predominantly by
regulation of cofilin rather than mDia activity. Alternatively,
it is possible that Diaphanous and LIMK signaling in
NIH3T3 and PC12 cells reflects a difference between the
treadmilling rates of RhoA-dependent F-actin in the two cell
types: in cells with a low basal mDia activity and treadmilling
rate, F-actin levels would be highly responsive to increased
mDia activity, whereas in cells with relatively high basal
mDia activity, F-actin might be effectively regulated via
LIMK; this might apply in PC12 cells. Direct measurements
of treadmilling rates in the two cell types and the develop-
ment of reagents specific for the activated states of LIMK
and mDia should also allow direct insights into these issues.
 
Materials and methods
 
Plasmids
 
LIMK1, N-WASP, and cofilin constructs are described elsewhere (Ishizaki
et al., 1997; Sahai et al., 1998; Sotiropoulos et al., 1999). Diaphanous
constructs encode mDia1 sequences as follows: Dia1*, residues 256–1255
 
(
 
 
 
N1
 
 
 
C; Watanabe et al., 1999); 
 
 
 
Dia1, 256–567; and dnDia1, 571–
1181 (lacking 750–771) (unpublished data). The 3D.Aluc reporter plasmid
contains the promoter sequences from 3D.ACAT (Sotiropoulos et al.,
1999) inserted into pGL3 (Promega).
 
Cell culture, transfection, and gene expression assays
 
PC12 cells were maintained on collagen-coated plates in DME with 6% FCS
and 6% horse serum and seed at 6 
 
 
 
 10
 
5
 
 cells per 6-cm dish before transfec-
tion using FuGene reagent (Roche) according to the manufacturer’s instruc-
tions. Each transfection mix (4 
 
 
 
g total plasmid DNA) included SRF reporter
plasmid 3D.ALuc (firefly luciferase; 0.1 
 
 
 
g), reference standard pRLTK (thymi-
dine kinase promoter controlling renilla luciferase; 0.4 
 
 
 
g), EF-eGFP (0.2 
 
 
 
g)
to monitor transfection efficiency, and EFplink expression vector or derivatives
encoding activator proteins or FLAG–cofilin (3.3 
 
 
 
g). For phosphorylation
studies, cofilin expression plasmids were used at 0.2 
 
 
 
g per transfection. From
control immunoblotting experiments with transfection efficiency estimated us-
ing GFP, we estimate that FLAG–cofilin was overexpressed by between two-
and fivefold (unpublished data). Transfected cells were maintained in 0.5% se-
rum for 18 h before stimulation with 15% serum; lysates were prepared 8 h
later. For reporter experiments, activities were normalized to the activity of a
parallel control transfection in which reporter activation was achieved using
the constitutively active SRF derivative SRFVP16 (50 ng; Dalton and Treisman,
1992), taken as 100. Each reporter figure shows mean 
 
 
 
 SEM for at least three
independent transfection experiments. RNA analysis and transfection of
mouse NIH3T3 cells were performed as previously described (Sotiropoulos et
al., 1999); total RNA (10 
 
 
 
g) was analyzed using mouse GAPDH and vinculin
probes with RNase T1 digestion (8 U per hybridization). Drug treatments were
as follows: cytochalasin D (2 
 
 
 
M; Calbiochem); jasplakinolide (0.5 
 
 
 
M; Mo-
lecular Probes); pretreatments for 45 min with Y27632 (10 
 
 
 
M; gift from
Yoshitomi Corp, Osaka, Japan) or latrunculin B (0.5 
 
 
 
M; Calbiochem).
 
2D gel electrophoresis assay for cofilin phosphorylation
Cells were washed with ice cold phosphate-buffered saline and fixed with
10% TCA for 15 min on ice before scraping and collection. The acetone-
washed cell pellet was solubilized with sonication in 2D sample buffer (8 M
urea, 4% CHAPS, 40 mM Tris base, 0.5% IPG buffers, pH 3–10; Amersham
Pharmacia Biotech), and cleared by centrifugation before loading Immobilon
strips with a linear pH gradient from 3 to 10 (Amersham Pharmacia Biotech).
First dimension electrophoresis was performed using the IPGphor isoelectric
focusing system (Amersham Pharmacia Biotech); second dimension was by
18% SDS-PAGE. Immunoblotting was performed by standard procedures
with detection by anti-FLAG antibody (M2; Sigma-Aldrich) for transfected
cells expressing FLAG–cofilin or the anti-cofilin antibody (Cytoskeleton).
Phosphatase treatment
Cells were washed with ice cold PBS and lysed directly on the plate (6-cm
dish) with 100  l of SDS lysis buffer (1% SDS, 10 mM EDTA, 5 mM NaF, 10
mM KH2PO4, 50 mM Tris, pH 8.1, with protease inhibitors) for 10 min on
ice and transferred to a test tube. The lysate was then diluted with 900  l of
IP dilution buffer (0.01% SDS, 1.1% triton, 1.2 mM EDTA, 167 mM NaCl, 5
mM NaF, 10 mM KH2PO4, 16.7 mM Tris, pH 8.0, with protease inhibitors)
and clarified by centrifugation before immunoprecipitation using anti-FLAG
beads (25  l) for 2 h at 4 C. Beads were then washed twice using IP buffer
and dispersed in 100  l of phosphatase buffer (50 mM Tris-HCl, pH 8.5, 1
mM EDTA) containing 20 U of alkaline phosphatase (Boehringer); control
beads were dispersed in 100  l phosphatase buffer containing 5 mM NaF
and 10 mM KH2PO4. Incubation was at 37 C for 1 h; beads were then col-
lected and cofilin was eluted using 2D sample buffer. For phosphatase treat-
ment of endogenous cofilin, lysates were prepared as above in IP buffer
lacking NaF and KH2PO4 and treated directly with 40 U alkaline phos-
phatase for 1 h at 37 C. Proteins were recovered by TCA precipitation and
processed for 2D gel analysis as above.
FACS
® quantitation of F-actin
For analysis of F-actin levels, FACS
® analysis was used to quantitate FITC-
phalloidin staining in fixed cell populations (Howard and Meyer, 1984; Bleul
et al., 1996; Burger et al., 1999). Five 6-cm plates of cells were transfected as
above using 1  g LIMK1 and 3  g mDia construct; one plate was retained
for a parallel luciferase assay. Trypsinized cells were washed sequentially
with DME/1% horse serum and PBS, and then resuspended in 0.5 ml PBS.
Cells were fixed by the addition of 0.5 ml 8% para-formaldehyde in PBS for
10 min at room temperature, washed in PBS, permeabilized in 1 mL of 0.3%
Triton X-100 in PBS, and washed again before incubation with anti-myc
9E10 antibody in 5% FCS in PBS for 45 min at 37 C. After removal of the pri-
mary antibody, the cells were stained with a 1/500 dilution of Cy3-conju-
gated anti–mouse antibody (Jackson ImmunoResearch Laboratories) to iden-838 The Journal of Cell Biology | Volume 157, Number 5, 2002
tify transfected cells and 33 nM FITC-phalloidin to measure F-actin content
in 5% FCS in PBS for 45 min at 37 C. Stained cells were sorted on a FACS-
can
® machine (Becton Dickinson) and the phalloidin staining was quantified
for transfected (Cy3 positive) and nontransfected (Cy3 negative) cells in each
sample. Gates for Cy3 were established using a mock transfected control cell
population. Mean F-actin content was evaluated and expressed as a percent-
age of that of untransfected cells from the same experiment.
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